Basic Information
FLUARIX TETRA SUSPENSION FOR INJECTION
INJECTION, SUSPENSION
Regulatory Information
SIN14760P
March 23, 2015
Prescription Only
Therapeutic
INTRAMUSCULAR
August 10, 2023
June 3, 2025
XJ07BB02
Company Information
GLAXOSMITHKLINE PTE LTD
GLAXOSMITHKLINE PTE LTD
Active Ingredients
Strength: 15mcg HA/0.5ml
Strength: 15mcg HA/0.5ml
Strength: 15mcg HA/0.5ml
Strength: 15mcg HA/0.5ml
Detailed Information
Contraindications
**3.3 Contraindications** Hypersensitivity to the active substances or to any of the excipients listed in _section 5.1_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ or to any component that may be present as traces such as eggs (ovalbumin, chicken proteins), formaldehyde, gentamicin sulphate and sodium deoxycholate. Immunisation should be postponed in patients with febrile illness or acute infection.
Indication Information
**3.1 Therapeutic indications** Fluarix Tetra is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine (see _Pharmacodynamics_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). The use of Fluarix Tetra should be based on official recommendations.